Biotech Values

[BTH]

All good catalysts.

IMO, 1135 is a much more compelling reason to own the stock at these levels, than 1127 is.

Its not surprising to hear they were/are having trouble enrolling 1135 because of Soliris. They actually got FDA approval to begin dosing in August of 2012....and almost a year later still didnt have a single patient dosed (they used the excuse they needed summer school vacation to start ).